Plant Extracellular Vesicle (EV): 30~150 nm small vesicles secreted by plant cells. Phospholipid bilayer + microRNA·protein·lipid contents. Can signal to human skin cells. Bypasses animal·stem-cell EV regulatory grey zone as vegan next-gen skincare ingredient.

Exosomes emerged as K-beauty next-gen core. But animal·human stem cell-derived = regulatory grey zone (drug vs cosmetic). Plant exosomes clarify regulation via plant extract classification, adding vegan·no animal testing·ethical value. L70 Exovive Lift (dsm-firmenich) clinical data proves plant EV achieves procedure-level effects clinically.

What it is

Exosome = Extracellular Vesicle (EV):

Secreted by all living cells
30~150 nm diameter
Outer phospholipid bilayer
Inner contents (microRNA·protein·lipid·DNA)

Plant EV:

Secreted by plant cells
Extracted from apple·citrus·ginseng·aloe·olive
Can signal human cells (via microRNA)
Vegan·no animal testing

Isolation·Purification

Process:

Plant (apple·citrus·ginseng) grinding
Centrifugation (differential·ultra)
Ultrafiltration
Size-exclusion chromatography
4 trillion vesicles/g concentration

Technical challenges:

EV content varies by plant
Purification losses
Stability (storage·distribution)
Cost (time·tech)

Mechanism

Skin absorption:

30~150 nm = penetrable size
Phospholipid bilayer = membrane fusion
Target cells (keratinocyte·epidermis·dermal fibroblast)

Cell signaling:

microRNA → target mRNA binding → gene expression modulation
Protein (growth factor·signaling) → direct action
Lipid → cell membrane integration·signaling

Hypothesized effects:

Collagen·elastin synthesis stimulation
Antioxidant·anti-inflammatory
Stem cell signaling mimicry
Senescent cell signal normalization

Plant EV vs Animal EV

Aspect	Plant EV	Animal EV (human stem cell)
Clinical data	Starting (L70 Exovive Lift)	Rich (10+ yr)
Regulation	Clear (plant extract)	Grey zone
Ethics	No animal testing·vegan	Human cells
Allergy	Low	Some concerns
Cost	Medium	High
K-beauty	New dimension	Some adoption

Major Plant EV Sources

Alpine Apple (Malus domestica):

‘Uttwiler Spätlauber’ variety
Storage-stable
Slow-aging apple → anti-aging implication
Exovive Lift (L70)

Mediterranean Citrus: Antioxidant·vitamin C, melanin regulation, Exovive Lift combo

Ginseng: Korean traditional anti-aging, saponins·ginsenosides, immune modulation

Aloe (Aloe vera): Hydration·soothing, burn·irritation recovery

Olive (Olea europaea): Polyphenols, antioxidant

L70 Exovive Lift Clinical Evidence

dsm-firmenich 2026.4 in-cosmetics Global:

2-month RCT n=45/arm (vs placebo)
Firmness +30%
Crow’s feet depth -15% vs placebo
8-year wrinkle reversal (skin aging timepoint)
4 trillion vesicles/g

Comparison:

Standard anti-aging cosmetic: +10~20% firmness
Post-procedure recovery: +20~30%
Exovive Lift +30% = procedure-level

L70 New Dimension - Plant EV Era

L65 New retinol 180-day: Standard anti-aging
L67 OS-01 senolytic body peptide: Senescent cell removal
L69 BASF NeoHelix collagen III +82%: Type-specific collagen
L70 Exovive Lift plant EV: Plant-derived extracellular vesicle new dimension

K-beauty topical next-gen ingredient.

Global Plant EV Competition

Exovive Lift (dsm-firmenich): L70, clinical data·global giant
Codif’s Hibiscus EV: Hibiscus-derived
Croda’s Plant EV: Various plants
Korean biotechs: Ginseng·green tea

Korean K-beauty strength: Ginseng·green tea·natural materials rich, cosmetics R&D strong, fast launch cycles

Korean Adoption Timeline

dsm-firmenich Exovive Lift:

B2B ingredient
Global cosmetic adoption (LG H&H·Amorepacific·L’Oreal)
Korean launch late 2026~2027
$100~$300/product expected

Usage·Expected Effects

Current (2026.5):

Some global brands topical
Korea launch 2026~2027

Expected use:

Serum form
Daily (AM·PM)
Add to standard anti-aging
8~12 wk consistency

Expected effects: Firmness·wrinkles, collagen synthesis, pores·fine lines

Limits and Unresolved

Limits: Clinical data accumulation early (vs animal EV 10+ yr), mechanism partially hypothetical (microRNA human action verification ongoing), cost (high vs other anti-aging), storage·stability tech needed

Unresolved: Plant-by-plant EV meta analysis, direct animal EV comparison clinical, long-term safety, Korean MFDS classification

FAQ

Q. Plant EV as effective as human stem cell EV? A. Direct comparison absent. Exovive Lift (+30% firmness) similar to some human stem cell EV. Plant EV strength = safety·regulation·vegan.

Q. Plant extract vs plant EV difference? A. Plant extract = grinding·extraction. Plant EV = purified vesicles (30~150nm). Penetration·signaling capability difference.

Q. Allergy risk? A. Plant allergies (apple·citrus) caution. But EV purified → ↓ allergy risk.

Q. Pregnancy·breastfeeding safe? A. Topical generally safe (↓ systemic absorption). But doctor consult recommended.

Q. Vegan certified? A. Plant-derived = vegan-friendly. Check capsule·other ingredients. ‘Vegan’ label.

MicroRNA (miRNA): 21~25 nt small RNA, gene expression regulation
Lipid bilayer: Phospholipid bilayer, cell membrane
Exocytosis: Extracellular secretion
Vesicle: Small sac
MVB: Multivesicular Body, EV production

Conclusion

Plant exosome (EV) bypasses animal·stem cell EV regulatory grey while entering vegan·clinical data·K-beauty next-gen core ingredient. Exovive Lift (L70) +30% firmness·8-year wrinkle reversal clinical = procedure-level effect possible. L70 = 35 pillars + plant EV dimension. Korea launch late 2026~2027. Vegan·ethics·clinical trio.

Plant Exosome (EV) — Bypassing Animal·Stem Cell EV Regulation. Vegan Next-Gen Skincare from Alpine Apple·Citrus·Ginseng·Aloe